Perkins Capital Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-57,150
Closed -$1.05M 123
2017
Q3
$1.05M Sell
57,150
-11,166
-16% -$193K 1.11% 28
2017
Q2
$1.13M Buy
68,316
+8,299
+14% +$115K 1.25% 21
2017
Q1
$828K Buy
60,017
+3,667
+7% +$58.9K 0.85% 41
2016
Q4
$1.07M Buy
56,350
+6,900
+14% +$132K 1.17% 29
2016
Q3
$1.1M Buy
49,450
+26,950
+120% +$506K 1.1% 32
2016
Q2
$411K Buy
+22,500
New +$387K 0.47% 65

Other funds holding ENTL

Perkins Capital Management's ENTL Position: Q4 2017 in Review

Perkins Capital Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 57,150 shares — an estimated $1.05M sold.

Perkins Capital Management first reported a position in ENTL in Q2 2016 and held it in 6 quarters. The position peaked at $1.13M in Q2 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Perkins Capital Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Perkins Capital Management sold 57,150 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $1.05M.
  • Perkins Capital Management first reported a position in Entellus Medical, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • Perkins Capital Management's Entellus Medical, Inc. Common Stock position peaked at $1.13M in Q2 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Perkins Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.